Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma ...

"We are proud to contribute to research in head and neck and other forms of cancer to learn more about causes and treatments.

Proton arc therapy offers a superior dose distribution compared with existing state-of-the-art proton delivery techniques ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.

A mother from Cannock who watched her identical twin boys go through tough cancer treatment - just weeks apart - has welcomed ...

Mean dose to the tongue mucosa did not improve predictions of taste impairment during and after radiation therapy compared ...

HPV causes irritating warts, or lesions, on the back, front, or side of the tongue. Males have a higher risk of developing ...

Professor and surgeon Jason Hunt, MD, MS, FACS, has been named inaugural Chair of the Department of Otolaryngology – Head and ...

"The best part of the job is hopefully curing somebody of cancer and giving them back the life they and their family wouldn’t ...

A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with ...

The FDA granted breakthrough therapy status to first-line petosemtamab plus pembrolizumab for PD-L1–positive recurrent or ...